MaxCyte Inc (MXCT)

1,070.00
+15.00(+1.41%)
  • Volume:
    70,887
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    1,070.00 - 1,070.00

MXCT Overview

Prev. Close
1,065
Day's Range
1,070-1,070
Revenue
19.01M
Open
1,065
52 wk Range
334-1,235
EPS
-0.13
Volume
70,887
Market Cap
1.07B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
175,348
P/E Ratio
-
Beta
0.49
1-Year Change
219.4%
Shares Outstanding
100,410,560
Next Earnings Date
17 Apr 2022
What is your sentiment on MaxCyte Inc?
or
Market is currently closed. Voting is open during market hours.

MaxCyte Inc News

MaxCyte Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Buy
Technical IndicatorsStrong SellSellSellSellStrong Buy
SummaryStrong SellStrong SellStrong SellSellStrong Buy

MaxCyte Inc Company Profile

MaxCyte Inc Company Profile

MaxCyte, Inc. (MaxCyte) is a life sciences company. The Company is focused on advancing the discovery, development and commercialization of cell therapies. The Company provide cell-engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology. MaxCyte has developed and commercialized Flow Electroporation platform, which facilitates engineering of a wide variety of cells. The Company's ExPERT platform, which is based on Flow Electroporation technology, is designed to address the expanding cell therapy market, and used across the continuum of the cell therapy sector. The ExPERT family of products includes: three instruments, the ATx, STx and GTx. MaxCyte has also developed CARMA, a therapeutic platform based on transfecting mRNA into unstimulated cells for the development of immune cell therapies.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.